Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection

BACKGROUND: A regimen of once-weekly rifapentine plus isoniazid for 3 months (3HP) is an effective treatment for subjects with latent tuberculosis infection; however, no reliable biomarker exists for predicting systemic adverse reactions (SARs) to 3HP treatment. METHODS: This prospective, multi-cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tsai-Yu, Feng, Jia-Yih, Shu, Chin-Chung, Lee, Susan Shin-jung, Chen, Chung-Yu, Wei, Yu-Feng, Lin, Chih-Bin, Huang, Wei-Chang, Su, Wei-Juin, Lin, Shu-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927064/
https://www.ncbi.nlm.nih.gov/pubmed/35308376
http://dx.doi.org/10.3389/fmicb.2022.821066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927064/
https://www.ncbi.nlm.nih.gov/pubmed/35308376
http://dx.doi.org/10.3389/fmicb.2022.821066

Ejemplares similares